51例儿科住院患者应用磷酸肌酸钠合理性分析

Rationality analysis in clinical use of creatine phosphate sodium in children:A report of 51 cases

  • 摘要: 目的 评价儿科使用磷酸肌酸钠的用药合理性,为临床合理用药提供参考。方法 收集2018年1-5月我院儿科住院患者中使用磷酸肌酸钠的病例,对其性别、年龄、临床诊断、联合用药等情况进行分析。结果 51例患儿中男性28例,女性23例;小于6岁37例(72.55%)。31例(60.78%)患儿的肌酸激酶同工酶指标大于24U/L并有明确的心肌损伤或心脏疾病相关诊断,属于合理用药;20例(39.22%)无心肌损伤或心脏疾病方面诊断的病例使用了磷酸肌酸钠治疗,属于无指征用药。41例(80.39%)联合使用了3种以上药物,32例(62.75%)联合应用了抗生素,治疗方案合理。结论 我院儿科磷酸肌酸钠使用情况基本合理,但在临床诊断检查和肝肾功能异常患儿个体化调整用量方面有待加强。

     

    Abstract: Objective To evaluate the clinical use of creatine phosphate sodium in children and provide evidence for rational drug use. Methods Totally 51 children who received intravenous administration of creatine phosphate sodium in our hospital from January to May in 2018 were collected,and their clinical data including age,gender,clinical diagnosis and drug combination were analyzed. Results Of the 51 cases,28 cases were male and 23 cases were female;37 cases (72.55%) were under 6 years old.Twenty cases (39.22%) received creatine phosphate sodium treatment without a diagnosis of myocardial injury or heart disease,which was off-label drug use;41 cases (80.39%) were given three kinds or more drugs;32 cases (62.75%) received medication treatment combined with antibiotic drugs with rationality. Conclusion Generally,the use of creatine phosphate sodium for children in our hospital is rational.We should pay attention to prescribe creatine phosphate sodium based on clinical diagnosis and adjust dosage for patients with liver or renal function abnormalities.

     

/

返回文章
返回